MPJE: Multistate Pharmacy Jurisprudence Examination • Pharmacy and Pharmacist Practice

Access Control — Apply minimum necessary and access control concepts to common workflow scenarios

Understanding how HIPAA's minimum necessary standard governs who sees what patient information in pharmacy practice.

MPJE emblem with a legal gavel, a medicine bottle, and scales.
Inside this lesson 10 sections 5 questions 5 figures

SECTION 1

Historical Context & Motivation

The concept of restricting access to sensitive health information is not new, but the modern regulatory framework that codifies these principles in pharmacy practice emerged over several decades of legislative and technological evolution. Before the digital age, patient records were kept in paper charts stored in locked cabinets, and access control was largely a matter of physical proximity and professional trust. As pharmacies began adopting electronic health records, computerized prescription processing systems, and networked databases, the potential for unauthorized access to protected health information (PHI) grew exponentially, creating an urgent need for formal access control regulations.

The legislative journey toward today's access control standards reflects a growing societal recognition that patient privacy is not merely an ethical aspiration but a legal right. Each milestone in this timeline represents a critical shift in how healthcare institutions—including pharmacies—are required to handle patient data. Understanding this history provides essential context for the minimum necessary standard that pharmacy professionals must apply in daily practice.

1974 • Privacy Act of 1974

Established fair information practices for federal agencies, laying early groundwork for restricting access to personal records held by the government and influencing later healthcare privacy frameworks.

1996 • HIPAA Enacted

The Health Insurance Portability and Accountability Act was signed into law, mandating national standards for electronic healthcare transactions and requiring the Secretary of HHS to develop privacy regulations for individually identifiable health information.

2003 • HIPAA Privacy Rule Compliance Deadline

Covered entities, including pharmacies, were required to comply with the Privacy Rule, which formally introduced the minimum necessary standard—mandating that uses and disclosures of PHI be limited to only the information needed to accomplish the intended purpose.

2005 • HIPAA Security Rule Enforcement Begins

The Security Rule required covered entities to implement administrative, physical, and technical safeguards—including role-based access controls—for electronic PHI (ePHI), directly impacting pharmacy information systems and workflow design.

2013 • HITECH Omnibus Rule Finalized

Strengthened HIPAA enforcement, extended obligations to business associates, increased breach notification requirements, and reinforced the minimum necessary standard with greater accountability and penalty structures for violations.

The central question that these regulations address is deceptively simple: How do we ensure that only the right people see only the right amount of patient information at the right time? In pharmacy practice, this question becomes particularly complex because pharmacists, technicians, interns, billing staff, and third-party payers all interact with PHI in different capacities and for different purposes. The access control and minimum necessary principles provide the regulatory and practical framework for answering this question consistently across every workflow scenario a pharmacy encounters.

SECTION 2

Core Principles & Definitions

Access control and the minimum necessary standard are complementary concepts rooted in the same regulatory philosophy: PHI should be treated as a restricted resource, accessible only to those who need it and only to the extent required for a legitimate purpose. The HIPAA Privacy Rule establishes the minimum necessary standard as a general requirement, while the HIPAA Security Rule operationalizes that requirement through specific access control mechanisms. Together, these principles form the backbone of information governance in pharmacy practice, and a firm grasp of each is essential for MPJE preparation.

1

Minimum Necessary Standard

A HIPAA Privacy Rule requirement (45 CFR § 164.502(b)) that covered entities must make reasonable efforts to limit PHI use, disclosure, and requests to the minimum amount necessary to accomplish the intended purpose. This applies to internal uses, routine disclosures, and requests for PHI from other entities.
2

Role-Based Access Control (RBAC)

A Security Rule implementation strategy where access permissions are assigned based on an individual's job function or role within the organization. A pharmacy technician, for example, may access prescription fill data but not clinical consultation notes restricted to the pharmacist.
3

Exceptions to Minimum Necessary

The minimum necessary standard does not apply to disclosures for treatment purposes between providers, disclosures to the individual patient, disclosures authorized by the patient, disclosures required by law, and disclosures to HHS for compliance investigations.
4

Technical Safeguards for Access Control

The Security Rule (45 CFR § 164.312(a)) requires covered entities to implement technical policies and procedures that allow only authorized persons to access ePHI. These include unique user identification, emergency access procedures, automatic logoff, and encryption/decryption mechanisms.
5

Audit Controls

Hardware, software, and procedural mechanisms that record and examine access activity in information systems containing ePHI. Audit trails enable pharmacies to detect inappropriate access and demonstrate compliance during inspections.
✦

KEY TAKEAWAY

Think of the minimum necessary standard like a hospital key card system. A nurse's badge opens doors to the units where they work but not to the pharmacy vault or the administrative offices. Similarly, each member of the pharmacy team should have an information "key card" that opens only the PHI they need for their specific role. The minimum necessary standard does not restrict treatment—a pharmacist communicating with a prescriber about a patient's therapy can share what is clinically necessary without applying this limitation. The restriction targets non-treatment uses such as billing, quality assurance, and internal operations.

SECTION 3

Visual Explanation — Access Tiers in Pharmacy Workflow

The following diagram illustrates how role-based access control creates distinct information tiers within a typical pharmacy. Each concentric ring represents an expanded scope of PHI access, with the most restricted data at the center and broader operational data at the periphery. This visual framework helps clarify why different team members are granted different levels of system access and how the minimum necessary principle maps to actual pharmacy software configurations.

Role-Based Access Control Tiers in Pharmacy PracticeTIER 4 — Administrative / Billing StaffInsurance info, claim data, aggregate reports (no clinical details)TIER 3 — Pharmacy TechniciansPrescription fill data, patient demographics, refill historyTIER 2 — Staff PharmacistsClinical notes, DUR alerts, patient counseling recordsTIER 1PIC / ComplianceFull PHI + audit logsInner rings = more PHI access · Outer rings = restricted to role-specific dataPharmacist-in-ChargeStaff PharmacistTechnicianAdmin / Billing
The concentric rings depict four access tiers commonly configured in pharmacy management systems. The pharmacist-in-charge (PIC) at the center has the broadest access, including audit logs and compliance reports. Each outer tier progressively limits the scope of PHI available, consistent with the minimum necessary standard.

Notice that the treatment exception to the minimum necessary standard does not appear as a separate tier—this is intentional. When a pharmacist communicates with a prescriber to clarify a prescription or discuss therapy modification, the exchange falls under the treatment exception, and the minimum necessary limitation does not apply. However, within the pharmacy's own information system, access is still governed by role-based controls. A technician processing a refill does not need access to the pharmacist's clinical consultation notes to perform their function, even though both are engaged in activities that support treatment. The distinction is between inter-provider communication (treatment exception applies) and intra-organizational system access (minimum necessary applies through RBAC).

SECTION 4

How Access Control Works in Practice

Implementing the minimum necessary standard in a pharmacy requires a systematic approach that translates a broad regulatory principle into concrete operational procedures. The HIPAA Privacy Rule does not prescribe a specific technical solution; instead, it requires each covered entity to develop and maintain policies that identify which workforce members need access to which categories of PHI to carry out their job duties. The Security Rule then complements this by requiring specific technical, administrative, and physical safeguards. Understanding the interplay between these two rules is essential for MPJE success.

The Three Categories of Safeguards

1

Administrative Safeguards

Policies designating a privacy/security officer, workforce training programs, sanctions for violations, and documentation of who has access to what PHI categories. These are the foundation upon which technical and physical controls are built.
2

Physical Safeguards

Facility access controls (locked areas, badge readers), workstation use policies (screen positioning away from public view), and device and media controls governing the movement and disposal of hardware containing ePHI.
3

Technical Safeguards

Unique user IDs, password policies, automatic logoff timers, encryption, and audit controls embedded in pharmacy management software. These mechanisms enforce role-based permissions at the system level.

Minimum Necessary Decision Framework

When a pharmacy workforce member encounters a situation involving PHI, they must apply a structured decision-making process. First, determine whether the use or disclosure falls under a minimum necessary exception (treatment, patient request, authorization, required by law, or HHS investigation). If an exception applies, the minimum necessary limitation does not restrict the disclosure. If no exception applies, the workforce member must then assess what specific PHI elements are needed for the purpose at hand and limit the disclosure accordingly. For routine, recurring disclosures (such as submitting claims to insurance), the pharmacy must establish standard protocols that limit the PHI included. For non-routine disclosures (such as responding to an attorney's subpoena), an individualized review must be conducted for each request.

💡

MPJE Exam Tip

A common MPJE distractor states that the minimum necessary standard applies to all disclosures. Remember the five exceptions: (1) disclosures for treatment, (2) disclosures to the individual, (3) disclosures pursuant to a valid authorization, (4) disclosures required by law, and (5) disclosures to HHS for compliance/enforcement. If the scenario involves a pharmacist calling a physician to clarify a dose, the minimum necessary standard does NOT apply.

SECTION 5

Applying Access Control to Common Pharmacy Workflows

The MPJE frequently tests candidates' ability to apply access control and minimum necessary principles to realistic pharmacy scenarios. The following diagram and table map common pharmacy workflow activities to the appropriate access control considerations, distinguishing situations where the minimum necessary standard applies from those where an exception governs.

Minimum Necessary Decision Flowchart for Pharmacy DisclosuresPHI Use or Disclosure RequestIs this for Treatment, Patient Request,Authorization, Required by Law, or HHS?YESEXCEPTIONMin. necessarydoes NOT applyNOIs this a routine, recurringdisclosure (e.g., insurance claims)?YESAPPLY STANDARDUse pre-establishedprotocol/policyNONon-routine disclosure(e.g., subpoena, research request)INDIVIDUAL REVIEWAssess each request individually;limit PHI to what is specifically neededException (no limit)Standard protocolCase-by-case review
This flowchart guides the pharmacist through the decision process for any PHI disclosure. Begin at the top: if one of the five exceptions applies (shown in green), the minimum necessary standard is not applicable. For routine disclosures (amber), pre-established policies govern the scope. For non-routine disclosures (pink), an individual assessment is required.
Workflow ScenarioMinimum Necessary Applies?Rationale
Pharmacist calls prescriber to clarify doseNoTreatment exception — provider-to-provider communication for patient care
Pharmacy submits insurance claimYesPayment operation — only include PHI fields required for adjudication
Patient requests copy of their own prescription recordsNoDisclosure to the individual — patient has right to full access to their records
Quality improvement committee reviews dispensing errorsYesHealthcare operations — use de-identified or limited data where possible
Attorney presents valid subpoena for patient recordsYesNon-routine disclosure — review individually; provide only records specified in the subpoena
HHS Office for Civil Rights requests records for compliance reviewNoHHS exception — must provide records as requested for enforcement activities
Technician accesses patient profile to process refillYes (internal use)Technician should access only fields necessary for refill processing, not full clinical notes

Common pharmacy workflow scenarios and minimum necessary applicability

SECTION 6

Worked Example — Applying Access Control to a Pharmacy Scenario

Consider the following realistic scenario that integrates multiple access control principles. This type of multi-layered analysis is representative of how the MPJE tests these concepts.

📝

Scenario

A community pharmacy receives a faxed request from a workers' compensation insurance carrier asking for the complete prescription profile of a patient who filed a workplace injury claim. The request includes the patient's name, date of birth, and policy number but does not include a signed patient authorization. The pharmacy technician retrieves the fax and brings it to the pharmacist. How should the pharmacy respond?

Analyzing the Workers' Compensation Request

  1. 1

    Step 1 — Identify the Type of Disclosure

    This is a disclosure to a third-party payer (workers' compensation carrier), which falls under payment/healthcare operations. However, workers' compensation disclosures are also governed by state law, which may permit disclosure without authorization for work-related injuries. The pharmacist must verify whether applicable state law authorizes this disclosure.
    Classification: Non-treatment disclosure to third-party payer
  2. 2

    Step 2 — Check for Minimum Necessary Exceptions

    Review the five exceptions: (1) Not a treatment disclosure. (2) Not a disclosure to the individual. (3) No signed authorization is included. (4) May be required by state workers' compensation law—this requires verification. (5) Not an HHS investigation. If state law requires the disclosure, the "required by law" exception may apply, removing the minimum necessary limitation. However, most states still expect disclosures to be limited to information relevant to the claim.
    No clear exception without state law verification — apply minimum necessary standard
  3. 3

    Step 3 — Apply the Minimum Necessary Standard

    The carrier requests the "complete prescription profile," but the minimum necessary standard requires the pharmacy to disclose only information reasonably related to the workers' compensation claim. The pharmacy should limit the disclosure to prescriptions for medications related to the workplace injury (e.g., pain medications prescribed after the injury date) and should not provide the patient's entire medication history, which may include unrelated prescriptions for chronic conditions.
    Disclose only injury-related prescriptions, not the full profile
  4. 4

    Step 4 — Determine Who Should Handle the Disclosure

    The technician retrieved the fax, which is appropriate since receiving correspondence is within a technician's role. However, the decision about what to disclose and the actual release of PHI to a third party should be handled by the pharmacist or a designated privacy officer, consistent with RBAC principles. The technician should not independently respond to the request.
    Pharmacist reviews and authorizes the disclosure; technician may prepare records under supervision
  5. 5

    Step 5 — Document and Audit

    The pharmacy must maintain a record of this disclosure as required under 45 CFR § 164.528 (accounting of disclosures). The record should include the date, the identity of the recipient (workers' compensation carrier), a description of the PHI disclosed, and the purpose. This documentation supports compliance and enables the patient to request an accounting of disclosures.
    Log the disclosure in the accounting of disclosures record

SECTION 7

Strengths, Common Pitfalls, and Enforcement Considerations

The minimum necessary standard and access control framework represent a balanced regulatory approach, but they also present challenges in implementation. Understanding both the strengths and common pitfalls prepares pharmacy professionals to avoid violations and helps MPJE candidates navigate nuanced exam questions that test the boundaries of these principles.

StrengthsCommon Pitfalls
Limits exposure of PHI, reducing breach risk and potential harm to patientsOver-restricting access can impede legitimate treatment activities; pharmacists must remember the treatment exception
RBAC simplifies management—permissions are tied to roles, not individuals, making onboarding and offboarding efficient"Role creep" occurs when employees accumulate permissions beyond their current role (e.g., a promoted technician retaining old access plus new access)
Audit trails create accountability and deter inappropriate access ("snooping")Failure to regularly review audit logs means violations go undetected; many pharmacies generate logs but never analyze them
Pre-established protocols for routine disclosures increase efficiency and consistencyTreating all disclosures as routine and applying standard protocols to non-routine requests without individual review
Scalable framework that applies to pharmacies of all sizes, from independent to chainSmall pharmacies may lack dedicated compliance staff, leading to informal or undocumented access policies that fail during audits

Strengths and common implementation pitfalls of the minimum necessary standard

✦

KEY TAKEAWAY

Think of access control violations like a security camera system in a retail store. The cameras are only useful if someone actually reviews the footage—similarly, audit logs are only effective if regularly reviewed. The most sophisticated role-based access system in the world cannot prevent violations if the organization treats compliance as a one-time configuration rather than an ongoing process. On the MPJE, recognize that the correct answer often involves both technical controls and administrative oversight working together.

SECTION 8

Connection to Advanced Privacy Concepts and Emerging Challenges

The minimum necessary standard and role-based access control represent foundational privacy principles, but the landscape of health information regulation continues to evolve. Pharmacy professionals should recognize how these core concepts connect to more advanced and emerging regulatory frameworks. As pharmacy practice expands into telepharmacy, central fill operations, and interoperable health information exchanges, the challenge of implementing access controls becomes increasingly complex.

Core ConceptAdvanced/Emerging ExtensionPharmacy Relevance
Minimum necessary standardData minimization (GDPR, state privacy laws)Pharmacies serving international patients or operating in states with enhanced privacy laws (e.g., California CCPA/CPRA) may face stricter data minimization requirements
Role-based access control (RBAC)Attribute-based access control (ABAC)ABAC considers context (location, time, device) in addition to role, enabling more granular controls—e.g., restricting remote access to ePHI during non-business hours
Audit controlsProactive anomaly detection (AI-driven monitoring)Advanced systems use machine learning to flag unusual access patterns (e.g., a technician accessing records of patients not on today's fill queue), moving from reactive to proactive compliance
Business associate agreementsHealth information exchange (HIE) data governanceAs pharmacies participate in state and regional HIEs, access control extends across organizational boundaries, requiring trust frameworks and consent management systems
42 CFR Part 2 (substance use disorder records)Segmented data access for sensitive categoriesPharmacies dispensing MAT (medication-assisted treatment) must apply even stricter access controls than standard HIPAA requires for substance use disorder treatment records

How foundational access control concepts connect to advanced privacy frameworks

While the MPJE primarily tests the foundational HIPAA requirements, candidates should be aware that state-specific pharmacy practice acts may impose additional access control obligations. Some states, for example, require pharmacy management systems to maintain separate access logs for controlled substance records, or impose additional restrictions on who may access prescription monitoring program (PMP) data. The principle remains the same—when state law is more restrictive than HIPAA, the more restrictive standard applies. This "more restrictive" analysis is itself a critical MPJE testing point.

SECTION 9

Practice Problems

Question 1: CONCEPTUAL

A pharmacist contacts a prescribing physician to discuss a potential drug interaction identified during a prospective drug utilization review. The pharmacist shares the patient's current medication list with the physician. Does the minimum necessary standard apply to this disclosure? Explain your reasoning.
Show answer
No, the minimum necessary standard does not apply in this situation. This is a disclosure for treatment purposes—a pharmacist communicating with a prescriber about a patient's drug therapy to ensure safe and effective medication use. Under HIPAA, the treatment exception (45 CFR § 164.502(a)(1)(ii)) exempts provider-to-provider communications made for the purpose of treatment from the minimum necessary requirement. The pharmacist may share what is clinically needed to address the drug interaction concern without being constrained to a formalized "minimum" data set. However, good professional practice still dictates sharing only clinically relevant information.

Question 2: BASIC

A pharmacy's billing department needs to submit a claim to a patient's insurance company. List three specific types of PHI that are appropriate to include in the claim submission, and identify one type of PHI that should be excluded under the minimum necessary standard.
Show answer
Appropriate PHI for a standard insurance claim includes: (1) the patient's name, date of birth, and insurance member ID for identification purposes; (2) the NDC number, quantity dispensed, and days' supply for the medication being billed; and (3) the prescriber's NPI and diagnosis code (ICD-10) if required by the payer. PHI that should be excluded includes the patient's complete medication profile or history of unrelated conditions, as this information is not necessary for processing the specific claim. The minimum necessary standard requires that only the data fields needed for claim adjudication be transmitted. Pre-established billing protocols should define these standard data elements to ensure consistency.

Question 3: INTERMEDIATE

A pharmacy intern is temporarily covering a shift and is given the same system login credentials as the pharmacist on duty. The intern uses these credentials to access a patient's clinical consultation notes to prepare for patient counseling. Identify all access control violations present in this scenario and explain which HIPAA provisions are implicated.
Show answer
This scenario contains multiple access control violations. First, sharing login credentials violates the HIPAA Security Rule's requirement for unique user identification (45 CFR § 164.312(a)(2)(i)), which mandates that each workforce member have a unique identifier for tracking access to ePHI. Without unique IDs, audit trails cannot accurately attribute access to a specific individual. Second, the intern accessing clinical consultation notes may violate role-based access policies if the pharmacy's RBAC system restricts intern access to a subset of pharmacist-level data. Third, the minimum necessary principle for internal use requires that workforce members access only the PHI needed for their assigned function; whether the intern needs full clinical notes for counseling preparation depends on the pharmacy's policies, but the use of another person's credentials circumvents whatever controls are in place. The pharmacy should provision a separate, role-appropriate login for the intern with permissions calibrated to their scope of practice.

Question 4: APPLIED

A chain pharmacy is implementing a new pharmacy management system and must configure role-based access controls. The pharmacy employs pharmacists, pharmacy technicians, pharmacy interns, a billing specialist, and a delivery driver. Design an access control matrix that specifies which PHI categories each role should be able to view, and justify your decisions using the minimum necessary standard.
Show answer
The access control matrix should reflect the minimum necessary standard by aligning PHI access with each role's job functions. Pharmacists should have access to full patient profiles including demographics, medication history, allergy information, clinical notes, DUR alerts, and prescriber communications because they perform clinical functions requiring comprehensive patient data. Pharmacy technicians should access demographics, current prescription queue, refill history, and basic allergy flags needed for prescription processing, but should not have access to detailed clinical consultation notes or DUR override documentation. Pharmacy interns should have access similar to technicians, with the potential for expanded clinical access under direct pharmacist supervision, depending on state law. The billing specialist should access insurance information, claim status, patient identifiers, and financial data but should have no access to clinical notes, diagnosis details beyond what is needed for coding, or prescriber communications. The delivery driver should access only the minimum information needed for delivery: patient name, address, and a prescription identifier—no access to medication names, diagnoses, or clinical information. Each tier reflects the principle that access should be limited to what is reasonably necessary for the specific role to function.

Question 5: CRITICAL THINKING

A pharmacy receives a request from a university researcher who wants prescription fill data for a study on opioid prescribing patterns in the community. The researcher is not a covered entity and does not have an IRB-approved waiver of individual patient authorization. The researcher argues that because the study serves a public health purpose, the pharmacy should release the data without patient authorization. Analyze this scenario, identifying all relevant HIPAA provisions and access control principles that apply, and recommend a compliant course of action.
Show answer
This scenario requires careful analysis of multiple HIPAA provisions. First, the researcher's claim that the data serves a public health purpose does not invoke the public health activities exception (45 CFR § 164.512(b)), which applies to disclosures to public health authorities, not to independent researchers. Second, without an IRB-approved waiver of authorization under 45 CFR § 164.512(i), the pharmacy cannot release identifiable PHI for research without individual patient authorization. Third, even if a valid waiver were obtained, the minimum necessary standard would apply because research is not a treatment activity—the pharmacy would need to provide only the data elements specified in the research protocol and approved by the IRB. The recommended course of action is multi-layered: (1) inform the researcher that identifiable PHI cannot be released without patient authorization or a valid IRB waiver; (2) offer to provide a de-identified data set under the Safe Harbor or Expert Determination methods (45 CFR § 164.514), which would not constitute PHI and therefore would not be subject to HIPAA restrictions; (3) if the researcher obtains an IRB waiver, conduct an individual review of the request to apply the minimum necessary standard, releasing only the specific data elements approved in the waiver documentation; and (4) document all communications and decisions in the pharmacy's compliance records.

SUMMARY

Summary — Access Control and the Minimum Necessary Standard

Summary

The minimum necessary standard under HIPAA requires covered entities, including pharmacies, to limit the use, disclosure, and request of protected health information (PHI) to the minimum amount reasonably necessary to accomplish the intended purpose. This standard applies to internal uses, routine disclosures (such as insurance claims), and non-routine disclosures (such as responses to subpoenas), but critically does not apply to five key exceptions: disclosures for treatment, disclosures to the patient, authorized disclosures, disclosures required by law, and disclosures to HHS for enforcement. Role-based access control (RBAC) operationalizes this standard at the system level by assigning information access permissions based on each workforce member's job function.

Effective implementation requires all three categories of HIPAA safeguards working in concert: administrative safeguards (policies, training, sanctions), physical safeguards (facility access, workstation security), and technical safeguards (unique user IDs, automatic logoff, encryption, audit controls). For routine disclosures, pharmacies should maintain pre-established standard protocols; for non-routine disclosures, an individual review is required. When state law is more restrictive than HIPAA, the more restrictive standard governs. Mastery of these principles is essential for both MPJE preparation and competent pharmacy practice.

Varsity Tutors • MPJE: Multistate Pharmacy Jurisprudence Examination • Access Control — Apply minimum necessary and access control concepts to common workflow scenarios